Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Two-Component Disaggregation of ROE

Allergan PLC, decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2019 -9.06% = -5.57% × 1.63
Dec 31, 2018 -7.83% = -5.01% × 1.56
Dec 31, 2017 -5.59% = -3.49% × 1.60
Dec 31, 2016 19.65% = 11.61% × 1.69
Dec 31, 2015 5.11% = 2.88% × 1.77

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The financial performance over the five-year period is characterized by significant volatility in profitability, shifting from a peak in 2016 to a sustained period of negative returns beginning in 2017.

Return on Assets (ROA)
A sharp increase is observed between 2015 and 2016, where ROA rose from 2.88% to 11.61%. This positive momentum was reversed in 2017, as the ratio dropped to -3.49%. A consistent downward trend continued thereafter, reaching -5.01% in 2018 and -5.57% by the end of 2019, indicating a deterioration in operational efficiency and asset productivity.
Financial Leverage
The leverage ratio remained relatively stable throughout the period, fluctuating within a narrow range between 1.56 and 1.77. A slight downward trend was evident from 2015 to 2018, followed by a minor increase to 1.63 in 2019. The consistency of this ratio suggests that changes in the capital structure were not the primary drivers of the overall return volatility.
Return on Equity (ROE)
ROE mirrored the trajectory of ROA, experiencing a peak of 19.65% in 2016 before shifting to negative values. From 2017 to 2019, ROE declined from -5.59% to -9.06%. Under the two-component DuPont framework, the sustained financial leverage acted as a multiplier on the negative ROA, thereby amplifying the losses and accelerating the decline in equity returns during the final three years of the analyzed period.

AI Ask an analyst for more


Three-Component Disaggregation of ROE

Allergan PLC, decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2019 -9.06% = -32.76% × 0.17 × 1.63
Dec 31, 2018 -7.83% = -32.28% × 0.16 × 1.56
Dec 31, 2017 -5.59% = -25.88% × 0.13 × 1.60
Dec 31, 2016 19.65% = 102.76% × 0.11 × 1.69
Dec 31, 2015 5.11% = 25.98% × 0.11 × 1.77

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The Return on Equity (ROE) exhibited significant volatility over the five-year period, transitioning from positive returns in 2015 and 2016 to a progressive decline into negative territory from 2017 through 2019. The terminal ROE of -9.06% indicates a deterioration in shareholder returns, primarily driven by a collapse in profitability rather than changes in asset efficiency or capital structure.

Net Profit Margin
The profitability component demonstrates the most extreme variance. Following a baseline of 25.98% in 2015 and an anomalous peak of 102.76% in 2016, the margin pivoted to a deep negative trajectory. The trend shifted to -25.88% in 2017 and continued to deteriorate, reaching -32.76% by 2019. This sustained negative margin is the primary catalyst for the negative ROE.
Asset Turnover
A consistent upward trend in asset efficiency is observed. The turnover ratio rose from 0.11 in 2015 and 2016 to 0.17 by 2019. This indicates a steady improvement in the company's ability to generate revenue from its asset base, although these gains were insufficient to offset the losses occurring at the net income level.
Financial Leverage
The leverage ratio remained relatively stable, with minor fluctuations between 1.77 in 2015 and 1.56 in 2018, before slightly increasing to 1.63 in 2019. The lack of significant volatility in this component suggests that the changes in ROE were not influenced by aggressive changes in debt financing or capital restructuring.

In summary, the DuPont analysis reveals a divergence between operational efficiency and profitability. While asset turnover improved steadily over the period, the drastic shift from an exceptional profit margin in 2016 to persistent net losses thereafter fundamentally eroded the ROE. The stability of financial leverage confirms that the decline in shareholder returns is an operational and profitability issue rather than a result of financial gearing.

AI Ask an analyst for more


Five-Component Disaggregation of ROE

Allergan PLC, decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2019 -9.06% = — × — × -26.99% × 0.17 × 1.63
Dec 31, 2018 -7.83% = — × — × -37.73% × 0.16 × 1.56
Dec 31, 2017 -5.59% = — × — × -60.85% × 0.13 × 1.60
Dec 31, 2016 19.65% = 1.15 × 0.91 × 98.64% × 0.11 × 1.69
Dec 31, 2015 5.11% = 1.66 × 0.66 × 23.53% × 0.11 × 1.77

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The Return on Equity (ROE) exhibited significant volatility between 2015 and 2019, peaking at 19.65% in 2016 before entering a sustained negative trend, reaching -9.06% by the end of 2019. This trajectory indicates a severe deterioration in shareholder returns, primarily driven by operational performance rather than changes in financial leverage or asset efficiency.

Operating Performance (EBIT Margin)
The EBIT Margin serves as the primary driver of ROE volatility. Following a substantial increase to 98.64% in 2016, the margin collapsed to -60.85% in 2017. While a gradual recovery was observed—with margins improving to -37.73% in 2018 and -26.99% in 2019—the persistence of negative operating margins fundamentally compromised the company's ability to generate positive returns.
Asset Efficiency (Asset Turnover)
A consistent upward trend is observed in asset turnover, which rose from 0.11 in 2015 and 2016 to 0.17 by 2019. This indicates a steady improvement in the efficiency of asset utilization to generate revenue, although these gains were insufficient to offset the impact of negative operating margins.
Financial Leverage
Financial leverage remained relatively stable throughout the period, fluctuating within a narrow range between 1.56 and 1.77. The slight decline from 1.77 in 2015 to 1.56 in 2018, followed by a minor increase to 1.63 in 2019, suggests that the volatility in ROE was not a result of significant changes in the capital structure or debt levels.
Tax and Interest Burden
For the period where data is available, the tax burden decreased from 1.66 in 2015 to 1.15 in 2016, while the interest burden improved from 0.66 to 0.91. These fluctuations indicate changes in the impact of taxation and interest expenses on net income during the initial phase of the analyzed period.

AI Ask an analyst for more


Two-Component Disaggregation of ROA

Allergan PLC, decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2019 -5.57% = -32.76% × 0.17
Dec 31, 2018 -5.01% = -32.28% × 0.16
Dec 31, 2017 -3.49% = -25.88% × 0.13
Dec 31, 2016 11.61% = 102.76% × 0.11
Dec 31, 2015 2.88% = 25.98% × 0.11

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The Return on Assets (ROA) exhibits significant volatility and a subsequent downward trend over the five-year period. After an initial increase from 2.88% in 2015 to a peak of 11.61% in 2016, the ROA shifted into negative territory starting in 2017 and continued to deteriorate, reaching -5.57% by the end of 2019.

Net Profit Margin
The primary driver of the ROA trajectory is the extreme volatility and eventual collapse of the Net Profit Margin. A substantial peak of 102.76% was recorded in 2016, followed by a sharp reversal to -25.88% in 2017. This negative trend intensified through 2018 and 2019, ending at -32.76%. The transition from high profitability to sustained losses indicates significant pressure on the bottom line, potentially stemming from non-operating losses or structural cost increases.
Asset Turnover
In contrast to the profitability metrics, the Asset Turnover ratio demonstrates a consistent and gradual improvement. Starting at 0.11 in 2015 and 2016, the ratio rose steadily to 0.13 in 2017, 0.16 in 2018, and 0.17 in 2019. This upward trend suggests an increase in the efficiency of asset utilization to generate revenue.
Two-Component Interaction
The disaggregation of ROA reveals a divergence between operational efficiency and profitability. While the company succeeded in improving its asset turnover over the period, these efficiency gains were insufficient to offset the severe decline in the Net Profit Margin. Consequently, the negative impact of the shrinking profit margins dominated the ROA calculation, leading to a persistent decline in overall asset productivity from 2017 through 2019.

AI Ask an analyst for more


Four-Component Disaggregation of ROA

Allergan PLC, decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2019 -5.57% = — × — × -26.99% × 0.17
Dec 31, 2018 -5.01% = — × — × -37.73% × 0.16
Dec 31, 2017 -3.49% = — × — × -60.85% × 0.13
Dec 31, 2016 11.61% = 1.15 × 0.91 × 98.64% × 0.11
Dec 31, 2015 2.88% = 1.66 × 0.66 × 23.53% × 0.11

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The Return on Assets (ROA) exhibited significant volatility between 2015 and 2019, characterized by a sharp peak in 2016 followed by a sustained transition into negative territory. While ROA grew from 2.88% in 2015 to 11.61% in 2016, it declined sharply to -3.49% in 2017 and continued to deteriorate, reaching -5.57% by the end of 2019.

EBIT Margin
The EBIT margin served as the primary driver of ROA volatility. A substantial increase occurred in 2016, where the margin reached 98.64%, significantly elevating overall profitability. However, this was followed by a severe reversal in 2017, with the margin dropping to -60.85%. Although the margin showed a gradual recovery trend from 2017 through 2019, ending at -26.99%, the operational performance remained deeply negative throughout the latter three years of the period.
Asset Turnover
In contrast to the operational margins, asset turnover demonstrated a consistent and positive upward trend. Starting at 0.11 in 2015 and 2016, the ratio improved steadily to 0.13 in 2017, 0.16 in 2018, and 0.17 in 2019. This indicates a progressive increase in the efficiency of asset utilization to generate revenue, although these gains were insufficient to offset the impact of negative EBIT margins on the final ROA.
Tax and Interest Burdens
Analysis of the burden ratios is limited to the first two years of the period. The tax burden decreased from 1.66 in 2015 to 1.15 in 2016, suggesting a reduction in the impact of taxes on pre-tax income. Simultaneously, the interest burden increased from 0.66 to 0.91 over the same period, indicating a change in the relationship between interest expenses and operating profit.

The overall divergence between the improving asset turnover and the collapsing EBIT margin suggests that the decline in ROA was not a result of operational inefficiency in asset use, but rather a result of significant losses at the operating level. The recovery trend in the EBIT margin since 2017 indicates a stabilization phase, though the company had not returned to positive ROA by the end of 2019.

AI Ask an analyst for more


Disaggregation of Net Profit Margin

Allergan PLC, decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2019 -32.76% = — × — × -26.99%
Dec 31, 2018 -32.28% = — × — × -37.73%
Dec 31, 2017 -25.88% = — × — × -60.85%
Dec 31, 2016 102.76% = 1.15 × 0.91 × 98.64%
Dec 31, 2015 25.98% = 1.66 × 0.66 × 23.53%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The financial performance exhibits extreme volatility over the analyzed period, characterized by a sharp peak in profitability followed by a sustained transition into negative margins.

Operating Profitability (EBIT Margin)
A significant fluctuation is observed in the EBIT margin, which surged from 23.53% in 2015 to a peak of 98.64% in 2016. This was followed by a precipitous decline in 2017, with the margin falling to -60.85%. Although the operating margin remained negative through 2019, a gradual narrowing of losses is evident, improving to -37.73% in 2018 and -26.99% in 2019.
Net Profitability (Net Profit Margin)
The net profit margin mirrors the volatility of the EBIT margin, reaching an exceptional 102.76% in 2016. This value, exceeding the operating margin, indicates the presence of significant non-operating gains or tax benefits during that period. From 2017 to 2019, the company experienced consistent net losses, with margins stabilizing between -25.88% and -32.76%, reflecting a period of sustained bottom-line deficits.
Tax and Interest Burdens
Between 2015 and 2016, the tax burden decreased from 1.66 to 1.15, suggesting a reduction in the relative impact of taxes on earnings. During the same interval, the interest burden increased from 0.66 to 0.91, indicating that a larger portion of operating income was allocated to debt service. No data is available for these components from 2017 through 2019.

AI Ask an analyst for more